PGEL.NS(PGEL.NS)
PGEL.NS
No analyst ratings available
No analyst price targets available for PGEL.NS
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E |
|---|---|---|---|
| Revenue Avg | $67.66B | $85.18B | $101.54B |
| Low | $62.88B | $77.47B | $93.24B |
| High | $73.18B | $94.47B | $111.37B |
| EBITDA Avg | $5.82B | $7.33B | $8.74B |
| Low | $5.41B | $6.66B | $8.02B |
| High | $6.30B | $8.13B | $9.58B |
| EBIT Avg | $4.81B | $6.06B | $7.22B |
| Low | $4.47B | $5.51B | $6.63B |
| High | $5.20B | $6.72B | $7.92B |
| Net Income Avg | $3.28B | $4.93B | $5.92B |
| Low | $3.13B | $4.12B | $5.29B |
| High | $3.60B | $6.09B | $6.67B |
| EPS Avg | $11.38 | $17.12 | $20.55 |
| Low | $10.86 | $14.28 | $18.37 |
| High | $12.48 | $21.11 | $23.14 |
| Analysts (Rev / EPS) | 9 / 7 | 9 / 9 | 4 / 3 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $8.76B | $17.03B | $21.34B |
| Low | $8.76B | $17.03B | $21.34B |
| High | $8.76B | $17.03B | $21.34B |
| EBITDA Avg | $754M | $1.47B | $1.84B |
| Low | $754M | $1.47B | $1.84B |
| High | $754M | $1.47B | $1.84B |
| EBIT Avg | $623M | $1.21B | $1.52B |
| Low | $623M | $1.21B | $1.52B |
| High | $623M | $1.21B | $1.52B |
| Net Income Avg | $173M | $894M | $1.33B |
| Low | $173M | $894M | $1.33B |
| High | $173M | $894M | $1.33B |
| EPS Avg | $0.60 | $3.10 | $4.60 |
| Low | $0.60 | $3.10 | $4.60 |
| High | $0.60 | $3.10 | $4.60 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 |